[Diabetes-talk] Fw: [meters
Mike Freeman
k7uij at panix.com
Mon Jul 20 00:13:56 UTC 2009
----- Original Message -----
From: "Patricia LaFrance-Wolf" <plawolf at earthlink.net>
To: "Blind-Diabetics at Yahoogroups. Com"
<blind-diabetics at yahoogroups.com>; "Acb-Diabetics at Acb. Org"
<acb-diabetics at acb.org>; "Doc Mahaber Dr." <trinispice at dslextreme.com>;
"Julie Cantrell" <JCantrell at juniorblind.org>; "Joy Steigel"
<jstigile at sbcglobal.net>
Sent: Saturday, July 18, 2009 11:20 PM
Subject: [acb-diabetics] meters
July 19, 2009
Standards Might Rise on Monitors for Diabetics
By GARDINER HARRIS
Federal officials may soon require improvements for the glucose monitors
used by more than 11 million diabetics in the United States.
The rise in the use of home glucose monitors, even by hospitals, is
pushing
the action by the Food and Drug Administration, which for decades has
followed
international standards that allow the devices to be wrong by as much as
20
percent. Such a wide error rate can leave patients vulnerable to severe
problems,
including seizures, unconsciousness and coma.
In June, the agency pressed the international group that sets the
standards
to tighten them. If the group refuses to act, the agency "may instead
recognize
other (higher) performance standards" on its own, according to a June
letter
from Dr. Margaret A. Hamburg, the agency commissioner.
A change in the international standards is the easiest and best option,
officials said. The International Organization for Standardization,
which
sets
the standards, can act quickly and broadly. But the F.D.A. can change
the
rules itself through a more time-consuming and cumbersome process.
Officials said they would keep pushing until monitor accuracy improves,
a
promise that diabetes doctors cheered. In a May letter, the American
Association
of Clinical Endocrinologists formally asked that the agency act on the
issue.
"Because of the highly variable quality of the meters and the glucose
testing strips in widespread use, the safety of our patients who depend
upon
those
meters is threatened," the letter said.
Khatereh Calleja, a spokeswoman for the Advanced Medical Technology
Association, which represents monitor manufacturers, responded, "We
think
the present
standard is working."
Diabetes has been diagnosed in 18 million people in the United States,
and
another 6 million are estimated to have the disease without knowing it.
It
is
the seventh leading cause of death and costs the United States an
estimated
$174 billion a year, with the federal Medicare program spending $1
billion
on diabetes test strips alone.
Of particular concern to federal officials is the increasing use of home
glucose monitors in hospitals. A landmark 2001 study published in The
New
England
Journal of Medicine found that using insulin to maintain low blood sugar
levels in critically ill patients, even those without diabetes, reduced
hospital
deaths by 34 percent - a result so astonishing that hospitals around the
world soon adopted the practice.
But instead of buying the highly accurate and expensive glucose monitors
used in the study, many hospitals bought cheaper home models never
approved
for
hospital use. More recent studies have shown that critically ill
hospital
patients whose glucose levels were kept low suffered more problems - the
opposite
result from 2001.
The difference, F.D.A. officials said, may have resulted because many
patients in the second study were checked with home monitors.
"We think this technology is not up to par for some of the protocols we
see
out there" like hospital treatment of critically ill patients, said Dr.
Alberto
Gutierrez, deputy director of the agency's in vitro diagnostics office.
"We
feel passionately that this is an important issue."
Besides having a wide error rate, many home monitors give the wrong
result
if patients are taking certain drugs like Tylenol or even vitamin C. The
Accu-Chek
monitors made by Roche can be confounded by drugs commonly used in
dialysis.
Julie A. Vincent, a Roche spokeswoman, said, "Every blood glucose
monitor
on the market has some limitation or interferences."
The F.D.A. issued warnings about the drug-related problems, but doctors
complain that they have a hard time keeping straight which drugs
conflict
with
which monitors.
"In the hospital setting, you really don't know how many deaths are due
to
things that may be related to meter accuracy," said Dr. Richard Hellman,
a
former
president of the endocrinology group. "I don't know how common it is,
but I
don't think it's rare."
A study by government researchers found that when comparing tests from
five
different popular monitors, results varied by as much as 32 percent. For
a
class science project recently, Morgan DiSanto-Ranney, 16, of Bishop
O'Connell High School in Arlington, Va., bought seven different glucose
monitors and
had her father, a diabetic, use all of them.
"What I found was that almost all of the meters were off from one
another by
60 to 75 points," Morgan said in an interview. Two of the meters -
Ascensia
Breeze and Ascensia Breeze II, both made by Bayer - differed by an
average
of 62 points, she said.
Staci Gouveia, a Bayer spokeswoman, said her company's monitors meet
federal
requirements. "If the F.D.A. standards change, Bayer will work with the
F.D.A.
to meet their requirements and assure the accuracy and effectiveness of
our
meter," Ms. Gouveia said.
Morgan's mother is Emilia DiSanto, a staff investigator for Senator
Charles
E. Grassley, Republican of Iowa. Briefed on Morgan's test and other
studies,
Mr. Grassley sent a letter to the F.D.A. in June asking officials to
review
the problem.
As a result of her project, Morgan's father lost faith in glucose
monitors.
"He doesn't use them as much anymore," she said.
That reaction is exactly what federal officials are hoping to avoid by
quietly pressing manufacturers to improve accuracy. Multiple studies
make
clear
that diabetics who routinely use monitors are healthier and suffer fewer
serious complications than those who do not.
Manufacturers have long complained that any requirement to improve
accuracy
would lead them to raise prices, which would discourage use.
"If we decrease the use of meters, you will have some fairly dire
consequences to health," Dr. Gutierrez said, but requiring stricter
accuracy
standards
"seems a reasonable and safe practice to do."
Every year, the F.D.A. receives reports of several deaths and thousands
of
injuries related to glucose monitor failures, but the reports represent
only
a fraction of the actual toll. Insulin-dependent diabetics slip into
unconsciousness once a year on average, and 40 percent suffer seizures
or
coma in
their lifetimes because of low blood sugar levels, according to the
American
Diabetes Association, which has long advocated stricter accuracy
standards
for monitors.
"Insulin is a dangerous drug, and if someone makes the wrong decision
about
its use because of a bad test, they could die," said Dr. David Sacks, an
associate
professor of pathology at Harvard Medical School.
Arturo R Rolla
arolla at comcast.net
arolla at bidmc.harvard.edu
arolla at hms.harvard.edu
[Non-text portions of this message have been removed]
__._,_.___
Messages in this topic
(1)
Reply (via web post) |
Start a new topic
Messages |
Files |
Photos |
Links |
Database |
Polls |
Calendar
MARKETPLACE
Mom Power: Discover the community of moms doing more for their families,
for
the world and for each other
Yahoo! Groups
Change settings via the Web
(Yahoo! ID required)
Change settings via email:
Switch delivery to Daily Digest |
Switch format to Traditional
Visit Your Group |
Yahoo! Groups Terms of Use |
Unsubscribe
Recent Activity
list of 1 items
1
New Members
list end
Visit Your Group
Drive Traffic
Sponsored Search
can help increase
your site traffic.
New business?
Get new customers.
List your web site
in Yahoo! Search.
Yahoo! Groups
Cat Owners Group
Connect and share with
others who love their cats
.
__,_._,___
__________ NOD32 4259 (20090719) Information __________
This message was checked by NOD32 antivirus system.
http://www.eset.com
More information about the Diabetes-Talk
mailing list